高血压合并疾病治疗阈值与降压目标值的进展  

Progress of Therapeutic Thresholds andAntihypertensive Targets Value ofHypertension Complicated Disease

作　　者：周钰璞 王营忠[1] 周文丽 

机构地区：[1]延安大学附属医院,陕西 延安

出　　处：《临床医学进展》2021年第9期4345-4350,共6页Advances in Clinical Medicine

摘　　要：高血压是我国心血管疾病中发病率最高的疾病,也是大血管靶器官损害或其他心血管病的重要危险因素。同时高血压已成为影响全球死亡率的第二大危险因素。其主要原因在于发病隐匿,其危害的知晓率低,用药依从性差和降压目标值僵硬性应用等多方面原因。现将高血压目前测量标准及其常见伴发的疾病中高血压的启动治疗阈值和降压目标要点综述如下。Hypertension is the disease with the highest incidence of cardiovascular diseases in China, and it is also an important risk factor for macrovascular target organ damage or other cardiovascular diseases. At the same time, hypertension has become the second largest risk factor for global mortality. The main reason is that the disease is hidden, the awareness rate of its harm is low, the compliance of medication is poor, the target value of blood pressure is rigid, and so on. In this paper, the current measurement standards of hypertension and the starting treatment threshold and antihypertensive target of hypertension in common concomitant diseases are summarized as follows.

关 键 词：高血压 血压 血压治疗的阈值与目标 脑卒中 自体动静脉内瘘 特殊人群 

分 类 号：R54[医药卫生—心血管疾病]